Download: The impact of AMNOG on benefit assessment and market access in Germany

This presentation entitled “The impact of AMNOG on benefit assessment and market access in Germany”  was given at last year’s Market Access USA conference by Dr Michael Kulig, PhD, MPH, Scientific Advisor, Medical Consultancy Department. Download the presentation to learn: AMNOG Overview (G-BA perspective) Current Issues (G-BA perspective) Patient-relevant endpoints Orphan drugs Existing markets Impact of assessments and resolutions Download …

market access, drug value, healthcare, evidence, ebook, market access usa

Download ebook: Essential Insights on demonstrating drug value in a challenging market

    How are pharma, payers and patients utilizing evidence of real world outcomes to better understand and demonstrate drug value and improve patient care? How is the global market access environment changing and how is this impacting on pharmaceutical organisations? What does pharma need to know about the diverse payer landscape, alternative payment plans and communicating and influencing decision making? These are some important questions …

Download: Where are we now with US payers on biosimilars pricing, uptake and reimbursement?

      At the Market Access World USA conference held last October 17th in Boston, Ken Walsh, Global Pricing & Market Access, Sandoz Biopharmaceuticals gave a presentation on "Where are We Now with US Payers on Biosimilars Pricing, Uptake and Reimbursement?"  In the presentation, he discusses biosimilars today in the US in light of BCPA / ACA reform, and …